[go: up one dir, main page]

GB2465814B - Method,composition and device for the treatment of enzymes and saccharides disorders - Google Patents

Method,composition and device for the treatment of enzymes and saccharides disorders

Info

Publication number
GB2465814B
GB2465814B GB0822158A GB0822158A GB2465814B GB 2465814 B GB2465814 B GB 2465814B GB 0822158 A GB0822158 A GB 0822158A GB 0822158 A GB0822158 A GB 0822158A GB 2465814 B GB2465814 B GB 2465814B
Authority
GB
United Kingdom
Prior art keywords
saccharides
disorders
enzymes
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0822158A
Other versions
GB0822158D0 (en
GB2465814A (en
Inventor
Tarig Sayed Mustafa Arbab
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Saccharides Science and Tech Ltd
Original Assignee
Saccharides Science and Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0811274A external-priority patent/GB2468629B/en
Application filed by Saccharides Science and Tech Ltd filed Critical Saccharides Science and Tech Ltd
Priority to GB1111470.9A priority Critical patent/GB2479294B/en
Publication of GB0822158D0 publication Critical patent/GB0822158D0/en
Publication of GB2465814A publication Critical patent/GB2465814A/en
Application granted granted Critical
Publication of GB2465814B publication Critical patent/GB2465814B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/40—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving amylase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
GB0822158A 2008-06-19 2008-12-04 Method,composition and device for the treatment of enzymes and saccharides disorders Expired - Fee Related GB2465814B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1111470.9A GB2479294B (en) 2008-06-19 2008-12-04 Method, composition and device for the treatment of enzymes and saccharides disorders

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0811274A GB2468629B (en) 2008-06-08 2008-06-19 Method, composition, device for the treatment of amylase malfunctions/inactivity in association with saccharides (mainly polysaccharides) based diseases
GBGB0821501.4A GB0821501D0 (en) 2008-06-08 2008-11-25 Method, composition, and device, for the treatment of enzymes and saccharides disorder

Publications (3)

Publication Number Publication Date
GB0822158D0 GB0822158D0 (en) 2009-01-14
GB2465814A GB2465814A (en) 2010-06-02
GB2465814B true GB2465814B (en) 2011-10-26

Family

ID=40289496

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0822158A Expired - Fee Related GB2465814B (en) 2008-06-19 2008-12-04 Method,composition and device for the treatment of enzymes and saccharides disorders

Country Status (1)

Country Link
GB (1) GB2465814B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2966734B1 (en) 2010-10-29 2014-07-18 Max Rombi COMPOSITION COMPRISING AT LEAST ONE PROTEOLYTIC ENZYME FOR ITS USE TO PREVENT THE SYNTHESIS OF TRIGLYCERIDES
GB201417386D0 (en) 2014-10-01 2014-11-12 Nofima As Sugar-depleted fruit or vegetable juice product, method of producing the same and use thereof to maintain health and treat and to prevent medical ailments
BR112018074355A2 (en) * 2016-05-24 2019-03-06 Shafer Kim composition of probiotics and digestive enzymes and method of preparation and use thereof
GB201614415D0 (en) 2016-08-24 2016-10-05 Pepsis Ltd Enzymes for the treatment of human enterometabolic dysfunction
EP3927180A1 (en) * 2019-02-19 2021-12-29 DSM IP Assets B.V. Method for reducing fructan in a food product with aid of invertase (ec 3.2.1.26)
CN109943607A (en) * 2019-04-08 2019-06-28 广州市合利源食品有限公司 Maltose and preparation method thereof
CN112957457B (en) * 2021-02-05 2022-05-17 山东大学 Cascade enzyme-like nano system for promoting diabetic wound healing and preparation method and application thereof
GB2622839A (en) * 2022-09-29 2024-04-03 Ateria Health Australia Pty Ltd A method for treating asthma

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0381173A2 (en) * 1989-02-02 1990-08-08 Abbott Laboratories Method and device for quantitative chromatography
WO2001098532A1 (en) * 2000-06-21 2001-12-27 Novapharm Research (Australia) Pty Ltd Enzyme detection and measurement
WO2002010708A2 (en) * 2000-08-01 2002-02-07 Charm Sciences, Inc. Hygiene monitoring
US20020061302A1 (en) * 1999-03-17 2002-05-23 Suntje Sander-Struckmeier Method for the treatment of diabetes
WO2002055069A1 (en) * 2001-01-12 2002-07-18 Finnfeeds Finland Oy Use of betaine in functional products having blood pressure lowering effects
US20030235858A1 (en) * 2002-06-21 2003-12-25 Ramanan Gopalan Method for selectively combining multiple membranes for assembly into test strips
WO2005011645A2 (en) * 2003-08-04 2005-02-10 Jallal Messadek Selected betaines and their uses
WO2006136159A2 (en) * 2005-06-24 2006-12-28 Novozymes A/S Lipases for pharmaceutical use
WO2006136160A2 (en) * 2005-06-24 2006-12-28 Novozymes A/S Proteases for pharmaceutical use
EP1875816A2 (en) * 2003-07-10 2008-01-09 Carl A. Forest Beverages with specialized supplements
US20080050451A1 (en) * 2006-06-16 2008-02-28 Mabry Helen C Methods for assessing dehydration and shock, assays and kits for the methods

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0381173A2 (en) * 1989-02-02 1990-08-08 Abbott Laboratories Method and device for quantitative chromatography
US20020061302A1 (en) * 1999-03-17 2002-05-23 Suntje Sander-Struckmeier Method for the treatment of diabetes
WO2001098532A1 (en) * 2000-06-21 2001-12-27 Novapharm Research (Australia) Pty Ltd Enzyme detection and measurement
WO2002010708A2 (en) * 2000-08-01 2002-02-07 Charm Sciences, Inc. Hygiene monitoring
WO2002055069A1 (en) * 2001-01-12 2002-07-18 Finnfeeds Finland Oy Use of betaine in functional products having blood pressure lowering effects
US20030235858A1 (en) * 2002-06-21 2003-12-25 Ramanan Gopalan Method for selectively combining multiple membranes for assembly into test strips
EP1875816A2 (en) * 2003-07-10 2008-01-09 Carl A. Forest Beverages with specialized supplements
WO2005011645A2 (en) * 2003-08-04 2005-02-10 Jallal Messadek Selected betaines and their uses
WO2006136159A2 (en) * 2005-06-24 2006-12-28 Novozymes A/S Lipases for pharmaceutical use
WO2006136160A2 (en) * 2005-06-24 2006-12-28 Novozymes A/S Proteases for pharmaceutical use
US20080050451A1 (en) * 2006-06-16 2008-02-28 Mabry Helen C Methods for assessing dehydration and shock, assays and kits for the methods

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
http://www.aace.com/meetings/ams/2007/pdfs/2007am-abstracts.pdf AACE 16th Annual Meeting & Clinical Congress April 11-15, 2007, 2007 Abstracts, Abstactà 327, Arbab & Elias, "Amzylite F 1.2 as an in-vitro and in-vivo glucose reducing agent" [accessed 26 arch 2009] *
Ola Loa, LLC Honolulu, HI 96814, http://www.drinkyourvitamins.com/kids-multi-supplement-facts.html, OLA LOA KIDS MULTI VITAMIN & http://www.drinkyourvitamins.com/ola-loa-announces-kids-multi-vitamin-product.html, press release dated 13 March 2006 [accessed 20 October 2010] *

Also Published As

Publication number Publication date
GB0822158D0 (en) 2009-01-14
GB2465814A (en) 2010-06-02

Similar Documents

Publication Publication Date Title
PL2894165T3 (en) Methods and compositions for treating complement-associated disorders
EP2170309A4 (en) Methods and compositions for treating disorders
IL209032A0 (en) Compositions and methods for treating digestive disorders
EP2059282A4 (en) Apparatus, methods and devices for treatment of ocular disorders
ZA200904684B (en) Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them
GB2466912B (en) Compositions and methods for treating lysosomal disorders
PT3135672T (en) Compositions and methods for treating alcohol use disorders, pain and other diseases
IL207132A0 (en) Composition and method for seed treatment use
GB2465814B (en) Method,composition and device for the treatment of enzymes and saccharides disorders
IL211642A0 (en) Method for the treatment of substrates, substrate and treatment device for carrying out said method
EP2252608A4 (en) Method for treating pain syndrome and other disorders
IL200570A0 (en) Combination therapy, composition and methods for the treatment of cardiovascular disorders
GB0604471D0 (en) Device and method for the treatment of tumours
PL1982178T3 (en) Methods for the treatment of affective disorders
GB0821501D0 (en) Method, composition, and device, for the treatment of enzymes and saccharides disorder
EP2246533A4 (en) Sliding member, and method for treating surface of the sliding member
ZA201003343B (en) Agent for improving sugarcane brix and method of promoting sugarcane ripening using the same
GB2479294B (en) Method, composition and device for the treatment of enzymes and saccharides disorders
PT2278962E (en) Methods for the treatment of dermatological disorders
GB0808326D0 (en) Compositions and methods for the treatment of fybromyalgia
HK1160784A (en) Methods and compositions for treating complement-associated disorders
AU2008900258A0 (en) Method for the treatment of mental disorders
AU2008901355A0 (en) Method for the treatment of mental disorders
AU2008902365A0 (en) Methods for treating muscle disorders and improving muscle form
HK1116020B (en) Treatment device and method of using the same

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20181204